$VTIX

Virtuix Q1 sales $767K, EPS ($0.22) beat estimates

Virtuix (VTIX) reported Q1 FY2027 net sales of $767K, beating estimates, with a net loss per share of ($0.22). Gross profit rose 29% to $227K, driven by higher selling prices. Operating expenses increased 86% to $4.1M. The company secured its first Omni One Enterprise sale to Tesla. Cash reserves stood at $7.4M. The earnings release and conference call were rescheduled to August 19-20, 2026, due to a new audit firm's review.

Original reporting
Published Aug 19, 2026, 9:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 11:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Virtuix Q1 sales $767K, EPS ($0.22) beat estimates — source image
Decision brief

The 30-second read

$VTIXBullishHigh
01

Why it matters

Earnings beat and new contract could trigger short‑term buying, but elevated expenses and cash burn warrant caution.

02

Market read

First‑report earnings beat for a micro‑cap tech firm with a notable enterprise contract.

03

What to watch

The rescheduled filing may signal accounting transition risk; investors should monitor cash runway.

Relevance 7/10Novelty 8/10Timing: after‑hours earnings release

Background

Virtuix reported Q1 FY27 results, beating estimates and announcing a new enterprise sale to Tesla.

Company-level read

Ticker impact

$VTIXBullishHigh confidence
Context

Q1 FY27 results beat sales and EPS estimates, providing fresh earnings data for Virtuix.

Expected impact

Potential modest price rise in after‑hours trading.

Evidence & confidence

Beat on both top‑line and EPS, plus new enterprise contract with Tesla, may attract buying pressure.

Market effects

Positive signal for XR/immersive tech sector and defense training contracts.

May boost investor interest in US micro‑cap tech stocks.

Limited to niche hardware market, but highlights growing enterprise adoption.

Counterpoint

Higher operating expenses and cash burn could pressure the stock if financing remains constrained.

Key entities

  • Virtuix Holdings Inc.

    Micro‑cap XR hardware manufacturer.

  • Tesla Inc.

    Customer for Virtuix's Omni One enterprise system.

Related articles

$VTIXMed

Quarterly revenue beat analyst expectations by more than 50% at Virtuix

Virtuix (VTIX) reported quarterly revenue exceeding analyst expectations by over 50%, driven by strong consumer demand for its Omni One platform. The company will present at the H.C. Wainwright conference, highlighting expansions into defense, robotics, healthcare, and enterprise markets, including partnerships with Tesla and the U.S. Marine Corps. VTIX stock declined 9.52% on the news.

$VTIXMed

Research firm sees 644% potential upside for Virtuix; orders rose 72% after Meta partnership

Emerging Growth Research reaffirmed its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), implying 644% upside. Q1 2027 revenue was $0.8M, down 26% YoY but above estimates, driven by a 72% rise in new orders post-Meta partnership. Gross margin expanded to 30%, and EPS improved sequentially to $(0.22). The firm projects 19% and 275% revenue growth for fiscal 2027 and 2028, respectively, but notes execution and financing risks.

$VTIXMed

Virtuix Holdings Inc. (VTIX): Results of Operations and Financial Condition

Virtuix Holdings Inc. (VTIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch Orders Increased 72% Year-over-Year and Approximately 150% Since the Launch of Omni One for Quest as Meta Launch Drives Accelerating Consumer Demand Gross Pr

$VTIXMed

Virtuix Reports 72% Year-over-Year Order Growth, Margin Expansion, and New Defense, Enterprise, and Healthcare Wins in Fiscal Q1 2027

Virtuix reported a 72% year-over-year increase in orders and a 29% rise in gross profit for Q1 2027. Gross margin expanded to 30% from 17%. The company secured new defense, enterprise, and healthcare contracts, including deals with Tesla, NASA, and the U.S. Marine Corps. Net sales were $0.8 million, down 26% year-over-year, but orders surged.